ProfileGDS4718 / 241299_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 14% 12% 8% 12% 12% 19% 11% 16% 10% 11% 19% 9% 11% 11% 13% 7% 19% 12% 29% 16% 13% 15% 14% 19% 11% 11% 14% 12% 8% 8% 13% 12% 13% 12% 15% 8% 12% 17% 18% 11% 11% 18% 7% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0673718
GSM549102patient 115, normal, homogenized [OPG study]3.9427514
GSM549104patient 119, normal, homogenized [OPG study]3.8417512
GSM549108patient 138, normal, homogenized [OPG study]3.712838
GSM549119patient 077, normal, homogenized [OPG study]3.8472212
GSM549133patient 032, cancer, homogenized [OPG study]3.8161912
GSM549139patient 042, cancer, homogenized [OPG study]4.0789119
GSM549099patient 107, normal, homogenized [OPG study]3.8224211
GSM549109patient 139, normal, homogenized [OPG study]4.0262516
GSM549110patient 046, normal, homogenized [OPG study]3.7716710
GSM549114patient 063, normal, homogenized [OPG study]3.7967111
GSM549122patient 082, normal, homogenized [OPG study]4.1068519
GSM549134patient 033, cancer, homogenized [OPG study]3.745819
GSM549136patient 036, cancer, homogenized [OPG study]3.7621511
GSM549140patient 044, cancer, homogenized [OPG study]3.7808311
GSM549111patient 047, normal, homogenized [OPG study]3.8783413
GSM549113patient 057, normal, homogenized [OPG study]3.655667
GSM549132patient 031, cancer, homogenized [OPG study]4.086719
GSM549137patient 038, cancer, homogenized [OPG study]3.8512112
GSM549142patient 047, cancer, homogenized [OPG study]4.5964129
GSM549100patient 110, normal, homogenized [OPG study]4.0173816
GSM549107patient 135, normal, homogenized [OPG study]3.8617313
GSM549115patient 068, normal, homogenized [OPG study]3.922115
GSM549116patient 072, normal, homogenized [OPG study]3.9211314
GSM549120patient 078, normal, homogenized [OPG study]4.0831119
GSM549131patient 030, cancer, homogenized [OPG study]3.7916311
GSM549118patient 074, normal, homogenized [OPG study]3.8117711
GSM549129patient 027, cancer, homogenized [OPG study]3.9502914
GSM549123patient 088, normal, homogenized [OPG study]3.8433212
GSM549124patient 006, cancer, homogenized [OPG study]3.718778
GSM549126patient 015, cancer, homogenized [OPG study]3.671968
GSM549128patient 025, cancer, homogenized [OPG study]3.8724213
GSM549103patient 117, normal, homogenized [OPG study]3.8989312
GSM549117patient 073, normal, homogenized [OPG study]3.8778313
GSM549138patient 041, cancer, homogenized [OPG study]3.8406312
GSM549141patient 045, cancer, homogenized [OPG study]3.9199315
GSM549130patient 028, cancer, homogenized [OPG study]3.692478
GSM549101patient 111, normal, homogenized [OPG study]3.8560812
GSM549105patient 128, normal, homogenized [OPG study]4.0590917
GSM549106patient 134, normal, homogenized [OPG study]4.0234618
GSM549112patient 048, normal, homogenized [OPG study]3.8009511
GSM549125patient 011, cancer, homogenized [OPG study]3.8081511
GSM549127patient 024, cancer, homogenized [OPG study]4.0648418
GSM549135patient 035, cancer, homogenized [OPG study]3.622127